Taiwan Weighs National Health Plan Coverage Of Tamiflu
This article was originally published in PharmAsia News
Executive SummaryTaiwan is considering whether to cover doses of Roche's Tamiflu (oseltamivir) under its national health insurance program. The health ministry and Centers for Disease Control expect a preliminary decision to be made before July 24. A decision for healthcare coverage would free hospitals to buy directly from Roche, but a concern is an immediate increase in demand for the antiviral could cause a nationwide shortage. One plan is to give priority to people who test positive for the H1N1 flu virus under a quick-screening process, with clinical doctors having the final say on who should receive priority. (Click here for more
You may also be interested in...
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.